Empyrean Capital Partners’s Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 CRU.WS Stock Holding History
Bought
Maintained
Sold
Other funds holding CRU.WS
LP
RCM
AI
PAMP
ICM
PC
AC
JG
Empyrean Capital Partners's CRU.WS Position: Q2 2022 in Review
Empyrean Capital Partners sold out of Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 (CRU.WS) in Q2 2022, closing a stake of 450,133 shares — an estimated $147K sold.
Empyrean Capital Partners first reported a position in CRU.WS in Q1 2021 and held it in 5 quarters. The position peaked at $626K in Q1 2021. 46 funds tracked by Wall St. Rank hold CRU.WS as of Q2 2022.
- Empyrean Capital Partners reported no remaining Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position as of Q2 2022 after selling out during the quarter.
- Empyrean Capital Partners sold 450,133 Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 shares in Q2 2022, an estimated $147K.
- Empyrean Capital Partners first reported a position in Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 in Q1 2021 and held it in 5 quarters.
- Empyrean Capital Partners's Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 position peaked at $626K in Q1 2021.
- 46 funds tracked by Wall St. Rank held Crucible Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one share of Class A common stock at an exercise price of $11.50 as of Q2 2022.
Based on Empyrean Capital Partners's 13F filing for Q2 2022, filed 15 Aug 2022.